Proposed Data Collections Submitted for Public Comment and Recommendations, 31191-31192 [E6-8453]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 105 / Thursday, June 1, 2006 / Notices
(BHC Act), Regulation Y (12 CFR Part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The application also will be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Additional information on all bank
holding companies may be obtained
from the National Information Center
website at www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than June 26, 2006.
A. Federal Reserve Bank of
Richmond (A. Linwood Gill, III, Vice
President) 701 East Byrd Street,
Richmond, Virginia 23261-4528:
1. New Century Bancorp, Inc., Dunn,
North Carolina; to acquire 100 percent
of the voting shares of Progressive State
Bank, Lumberton, North Carolina.
Board of Governors of the Federal Reserve
System, May 26, 2006.
Jennifer J. Johnson,
Secretary of the Board.
[FR Doc. E6–8506 Filed 5–31–06; 8:45 am]
BILLING CODE 6210–01–S
Federal Reserve System
Sunshine Act Meeting
Board of
Governors of the Federal Reserve
System.
TIME AND DATE: 11 a.m., Monday, June 5,
2006.
PLACE: Marriner S. Eccles Federal
Reserve Board Building, 20th and C
Streets, NW., Washington, DC 20551.
STATUS: Closed.
MATTERS TO BE CONSIDERED:
wwhite on PROD1PC61 with NOTICES
AGENCY HOLDING THE MEETING:
VerDate Aug<31>2005
19:10 May 31, 2006
Jkt 208001
1. Personnel actions (appointments,
promotions, assignments,
reassignments, and salary actions)
involving individual Federal Reserve
System employees.
2. Any items carried forward from a
previously announced meeting.
FOR FURTHER INFORMATION CONTACT:
Michelle Smith, Director, or Dave
Skidmore, Assistant to the Board, Office
of Board Members at 202–452–2955.
SUPPLEMENTARY INFORMATION: You may
call 202–452–3206 beginning at
approximately 5 p.m. two business days
before the meeting for a recorded
announcement of bank and bank
holding company applications
scheduled for the meeting; or you may
contact the Board’s Web site at https://
www.federalreserve.gov for an electronic
announcement that not only lists
applications, but also indicates
procedural and other information about
the meeting.
Board of Governors of the Federal Reserve
System, May 26, 2006.
Jennifer J. Johnson,
Secretary of the Board.
[FR Doc. 06–5038 Filed 5–26–06; 5:11 pm]
BILLING CODE 6210–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–06–0242x]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Seleda Perryman,
CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS–D74,
Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
31191
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Estimating the Cost of Sigmoidoscopy
and Colonoscopy for Colorectal Cancer
Screening in U.S. Healthcare
Facilities—New—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Colorectal cancer (CRC) is the second
leading cause of cancer-related deaths in
the United States. In 2005, it was
estimated that approximately 56,300
Americans died from CRC and about
145,300 new cases were diagnosed. The
risk of developing CRC increases with
advancing age. More than 90% of newly
diagnosed CRCs occur in persons 50
years of age and older. Several scientific
studies have demonstrated that regular
screening for CRC reduces the incidence
and mortality cases stemming from this
disease. Other studies have shown that
regular screening for CRC is also costeffective in terms of years of life saved.
Despite strong scientific evidence and
evidence-based clinical guidelines
recommending screening, current
screening rates remain low. A recent
CDC study reported that more than 40
million Americans who are 50 years of
age or older and at average risk for CRC
have not been screened in accordance
with current guidelines. The study also
reported that screening this population
with current endoscopic (i.e., flexible
sigmoidoscopy and colonoscopy)
capacity in the health care system could
require as much as ten years to
complete. An effective national effort to
promote CRC screening could increase
the demand for endoscopic procedures.
It has been reported that
reimbursements for endoscopic
procedures in publicly-funded programs
may not be adequate to cover the costs
of performing these procedures. This
may be a disincentive for providers to
perform endoscopy procedures.
Currently, there is little information
available about the resources required or
the cost of providing these procedures
in different types of healthcare facilities
in the United States.
The purpose of this project is to
conduct a survey of a nationally
representative sample of healthcare
E:\FR\FM\01JNN1.SGM
01JNN1
31192
Federal Register / Vol. 71, No. 105 / Thursday, June 1, 2006 / Notices
facilities in order to estimate the average
variable costs of providing colonoscopy
and flexible sigmoidoscopy for CRC
screening and follow-up services. Over
time, payments need to cover fixed costs
in addition to variable costs. If some
facilities have the ability to provide
more procedures without additional
investment in space or equipment, then
recovering fixed costs is not necessary at
least in the short run. The estimated
average variable cost by procedure will
be compared to the reimbursement rates
for both screening procedures in order
to determine whether the payments to
facilities exceed this minimum
threshold. Otherwise, facilities will find
reimbursement a potential barrier to
expansion of CRC screening to
uninsured or underinsured populations
even if there is underutilized capacity.
The study will also determine whether
there are factors that affect average
variable costs across facilities such as
the number of procedures performed,
specialization in types of procedures or
other characteristics of the facility.
Results of this study will be used to
better understand the economics of
colorectal cancer screening.
Respondents include medical facility
receptionists, hospital operators, and
office/business managers. There is no
cost to the respondent, other than their
time.
ESTIMATED ANNUALIZED BURDEN HOURS
Form type
Number of respondents
Number of responses per
respondent
Average burden per response (in
hours)
Telephone script to medical facility receptionists ............................................
Mail Survey to hospital-based outpatient department managers ....................
Mail Survey to ambulatory surgery center managers .....................................
Total ..........................................................................................................
4,160
1,000
725
........................
1
1
1
........................
5/60
1
1
........................
Dated: May 24, 2006.
Joan F. Karr,
Acting Report Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–8453 Filed 5–31–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panels (SEP): Surveillance
and Epidemiologic Research of
Duchenne and Becker Muscular
Dystrophy and Other Single Gene
Disorders, Request for Applications
(RFA) Number DD06–002
wwhite on PROD1PC61 with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting:
Name: Disease, Disability, and Injury
Prevention and Control Special Emphasis
Panel (SEP): Surveillance and Epidemiologic
Research of Duchenne and Becker Muscular
Dystrophy and Other Single Gene Disorders,
Request for Applications (RFA) Number
DD06–002.
Time and Date: 12 p.m.–5 p.m., June 27,
2006 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: To conduct expert
review of scientific merit of research
VerDate Aug<31>2005
20:00 May 31, 2006
Jkt 208001
applications: Surveillance and Epidemiologic
Research of Duchenne and Becker Muscular
Dystrophy and Other Single Gene Disorders,
RFA Number DD06–002.
FOR FURTHER INFORMATION CONTACT:
Juliana Cyril, PhD., Scientific Review
Administrator, Centers for Disease
Control, 1600 Clifton Road, NE., Mail
Stop D–72, Atlanta, GA 30333,
Telephone 404.639.4639.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: May 24, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–8443 Filed 5–31–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panels (SEP): Research and
Development Contract Attention Deficit
Hyperactivity Disorder Surveillance,
Contract Solicitation Number (CSN)
2006–N–08468
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
Total burden
hours
347
1,000
725
2,072
Control and Prevention (CDC)
announces the following meeting:
Name: Disease, Disability, and Injury
Prevention and Control Special Emphasis
Panel (SEP): Research and Development
Contract Attention Deficit Hyperactivity
Disorder Surveillance, CSN 2006–N–08468.
Time and Date: 12 p.m.–4 p.m., June 22,
2006 (Closed).
Place: Centers for Disease Control, 1600
Clifton Road NE., Building 19, Room 8123,
Atlanta, GA 30333.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of applications received in
response to ‘‘Research and Development
Contract Attention Deficit Hyperactivity
Disorder Surveillance,’’ CSN 2006–N–08468.
Contact Person for More Information:
Christine Morrison, Ph.D., Scientific Review
Administrator, Office of Extramural
Research, CDC, 1600 Clifton Road NE.,
Mailstop D72, Atlanta, GA 30333, Telephone
404–639–3098.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: May 24, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–8444 Filed 5–31–06; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\01JNN1.SGM
01JNN1
]]>Agencies
[Federal Register Volume 71, Number 105 (Thursday, June 1, 2006)]
[Notices]
[Pages 31191-31192]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-8453]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60 Day-06-0242x]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Seleda Perryman, CDC Assistant Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Estimating the Cost of Sigmoidoscopy and Colonoscopy for Colorectal
Cancer Screening in U.S. Healthcare Facilities--New--National Center
for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers
for Disease Control and Prevention (CDC).
Background and Brief Description
Colorectal cancer (CRC) is the second leading cause of cancer-
related deaths in the United States. In 2005, it was estimated that
approximately 56,300 Americans died from CRC and about 145,300 new
cases were diagnosed. The risk of developing CRC increases with
advancing age. More than 90% of newly diagnosed CRCs occur in persons
50 years of age and older. Several scientific studies have demonstrated
that regular screening for CRC reduces the incidence and mortality
cases stemming from this disease. Other studies have shown that regular
screening for CRC is also cost-effective in terms of years of life
saved.
Despite strong scientific evidence and evidence-based clinical
guidelines recommending screening, current screening rates remain low.
A recent CDC study reported that more than 40 million Americans who are
50 years of age or older and at average risk for CRC have not been
screened in accordance with current guidelines. The study also reported
that screening this population with current endoscopic (i.e., flexible
sigmoidoscopy and colonoscopy) capacity in the health care system could
require as much as ten years to complete. An effective national effort
to promote CRC screening could increase the demand for endoscopic
procedures.
It has been reported that reimbursements for endoscopic procedures
in publicly-funded programs may not be adequate to cover the costs of
performing these procedures. This may be a disincentive for providers
to perform endoscopy procedures. Currently, there is little information
available about the resources required or the cost of providing these
procedures in different types of healthcare facilities in the United
States.
The purpose of this project is to conduct a survey of a nationally
representative sample of healthcare
[[Page 31192]]
facilities in order to estimate the average variable costs of providing
colonoscopy and flexible sigmoidoscopy for CRC screening and follow-up
services. Over time, payments need to cover fixed costs in addition to
variable costs. If some facilities have the ability to provide more
procedures without additional investment in space or equipment, then
recovering fixed costs is not necessary at least in the short run. The
estimated average variable cost by procedure will be compared to the
reimbursement rates for both screening procedures in order to determine
whether the payments to facilities exceed this minimum threshold.
Otherwise, facilities will find reimbursement a potential barrier to
expansion of CRC screening to uninsured or underinsured populations
even if there is underutilized capacity. The study will also determine
whether there are factors that affect average variable costs across
facilities such as the number of procedures performed, specialization
in types of procedures or other characteristics of the facility.
Results of this study will be used to better understand the economics
of colorectal cancer screening.
Respondents include medical facility receptionists, hospital
operators, and office/business managers. There is no cost to the
respondent, other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Form type Number of responses per per response Total burden
respondents respondent (in hours) hours
----------------------------------------------------------------------------------------------------------------
Telephone script to medical facility 4,160 1 5/60 347
receptionists..................................
Mail Survey to hospital-based outpatient 1,000 1 1 1,000
department managers............................
Mail Survey to ambulatory surgery center 725 1 1 725
managers.......................................
Total....................................... .............. .............. .............. 2,072
----------------------------------------------------------------------------------------------------------------
Dated: May 24, 2006.
Joan F. Karr,
Acting Report Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E6-8453 Filed 5-31-06; 8:45 am]
BILLING CODE 4163-18-P
